Telehealth Companies Restrict Weight-Loss Drug Access as Employers Seek to Curb $1,000-Plus Monthly Costs
Updated
Updated · NPR · Jun 14
Telehealth Companies Restrict Weight-Loss Drug Access as Employers Seek to Curb $1,000-Plus Monthly Costs
3 articles · Updated · NPR · Jun 14
Summary
Telehealth providers are tightening eligibility for obesity drugs, screening which patients can receive the medicines through employer-backed programs.
Employers are pushing those limits to contain spending on weight-loss treatments that can cost more than $1,000 a month per patient.
The companies still pair drug access with lifestyle coaching and other support, arguing that patients have better odds of sustained weight loss when treatment is managed closely.
The shift shows how fast-growing demand for obesity drugs is forcing employers and telehealth firms to balance clinical access against benefit costs.